Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Profit Before Tax

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Profit Before Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax ₹2,291 Cr₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr

What is the latest Profit Before Tax of NATCO PHARMA ?

The latest Profit Before Tax ratio of NATCO PHARMA is ₹2,291 Cr based on Mar2025 Consolidated results.
Year Profit Before Tax
Mar2025₹2,291 Cr
Mar2024₹1,674 Cr
Mar2023₹862 Cr
Mar2022₹202 Cr
Mar2021₹580 Cr

How is Profit Before Tax of NATCO PHARMA Trending?

Years Profit Before Tax % Change
Mar2025 ₹2,291 Cr
36.92
Mar2024 ₹1,674 Cr
94.16
Mar2023 ₹862 Cr
326.26
Mar2022 ₹202 Cr
-65.11
Mar2021 ₹580 Cr -

Compare Profit Before Tax of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,861.7 Cr 1.4% -10.4% -28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1.4%

-10.4%

-28.4%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses